drugset / Trial / NCT05153317
Evaluation of Long-term Safety and Efficacy of ELX/TEZ/IVA in Cystic Fibrosis (CF) Participants 2 Years and Older
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the long term safety, tolerability, efficacy and pharmacodynamics of elexacaftor (ELX)/tezacaftor (TEZ)/ivacaftor (IVA) in CF participants 2 years of age and older.
Timeline
- Start
- 2022-01-17
- Primary completion
- 2026-01-29
- Completion
- 2026-01-29
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ivacaftor | Other / unclassified | — | Oral |
| Subject | elexacaftor | Small molecule | — | Oral |
| Subject | tezacaftor | Other / unclassified | — | Oral |